awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q48008083-128672C9-4FF3-401C-8931-24999386EE54
Q48008083-128672C9-4FF3-401C-8931-24999386EE54
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48008083-128672C9-4FF3-401C-8931-24999386EE54
Developmental Therapeutics in Myeloproliferative Neoplasms.
P2860
Q48008083-128672C9-4FF3-401C-8931-24999386EE54
BestRank
Statement
http://www.wikidata.org/entity/statement/Q48008083-128672C9-4FF3-401C-8931-24999386EE54
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1a57bf24c4c13ee4ef05e0fec59650ad4e82c39f
P2860
Long-term outcomes of 107 patients with myelofibrosis receiving JAK1/JAK2 inhibitor ruxolitinib: survival advantage in comparison to matched historical controls